Garofalo Health (Germany) Performance
| GHC Stock | EUR 5.30 0.02 0.38% |
The company retains a Market Volatility (i.e., Beta) of -0.2, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Garofalo Health are expected to decrease at a much lower rate. During the bear market, Garofalo Health is likely to outperform the market. At this point, Garofalo Health Care has a negative expected return of -0.0294%. Please make sure to check out Garofalo Health's treynor ratio, value at risk, and the relationship between the sortino ratio and maximum drawdown , to decide if Garofalo Health Care performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Garofalo Health Care has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Garofalo Health is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 24.8 M | |
| Total Cashflows From Investing Activities | -92.1 M |
Garofalo |
Garofalo Health Relative Risk vs. Return Landscape
If you would invest 542.00 in Garofalo Health Care on October 11, 2024 and sell it today you would lose (12.00) from holding Garofalo Health Care or give up 2.21% of portfolio value over 90 days. Garofalo Health Care is currently producing negative expected returns and takes up 1.2741% volatility of returns over 90 trading days. Put another way, 11% of traded stocks are less volatile than Garofalo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Garofalo Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Garofalo Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Garofalo Health Care, and traders can use it to determine the average amount a Garofalo Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0231
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GHC |
Estimated Market Risk
| 1.27 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Garofalo Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Garofalo Health by adding Garofalo Health to a well-diversified portfolio.
Garofalo Health Fundamentals Growth
Garofalo Stock prices reflect investors' perceptions of the future prospects and financial health of Garofalo Health, and Garofalo Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Garofalo Stock performance.
| Return On Equity | 0.0851 | |||
| Return On Asset | 0.0425 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 467.88 M | |||
| Shares Outstanding | 89.09 M | |||
| Price To Earning | 40.71 X | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 1.07 X | |||
| Revenue | 277.87 M | |||
| EBITDA | 43.72 M | |||
| Cash And Equivalents | 24.94 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 116.57 M | |||
| Debt To Equity | 0.60 % | |||
| Book Value Per Share | 2.92 X | |||
| Cash Flow From Operations | 36.31 M | |||
| Earnings Per Share | 0.25 X | |||
| Total Asset | 626.51 M | |||
About Garofalo Health Performance
By analyzing Garofalo Health's fundamental ratios, stakeholders can gain valuable insights into Garofalo Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Garofalo Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Garofalo Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Garofalo Health Care S.p.A. operates healthcare centers in Italy. It operates 19 healthcare facilities located in Piedmont, Veneto, Tuscany, Emilia-Romagna, Lazio, and Liguria. GAROFALO HEALTH operates under Medical Care Facilities classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1187 people.Things to note about Garofalo Health Care performance evaluation
Checking the ongoing alerts about Garofalo Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Garofalo Health Care help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Garofalo Health Care generated a negative expected return over the last 90 days | |
| About 64.0% of the company shares are held by company insiders |
- Analyzing Garofalo Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Garofalo Health's stock is overvalued or undervalued compared to its peers.
- Examining Garofalo Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Garofalo Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Garofalo Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Garofalo Health's stock. These opinions can provide insight into Garofalo Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Garofalo Stock analysis
When running Garofalo Health's price analysis, check to measure Garofalo Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Garofalo Health is operating at the current time. Most of Garofalo Health's value examination focuses on studying past and present price action to predict the probability of Garofalo Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Garofalo Health's price. Additionally, you may evaluate how the addition of Garofalo Health to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |